Analysed AXIM BIOTECHNOLOGIES INC (AXIM:OTCMKTS) News Sources
AXIM Biotechnologies, Inc. and Medical Marijuana, Inc. Enter Into Strategic Alliance to Research and Develop Applications and Uses of Patent for Water Soluble Cannabinoids
29-01-2026
yahoo.com
Medical Marijuana, Inc. and AXIM Biotechnologies, Inc. Enter Into Strategic Alliance to Research and Develop Applications and Uses of Patent for Water Soluble Cannabinoids
29-01-2026
yahoo.com
AXIM Biotechnologies Engages 624 Advisors, Owned and Managed by Dr. Alan J. Touch, Innovator and Global Regulatory Leader, as Chief Medical & Regulatory Affairs Advisor
20-01-2026
yahoo.com
AXIM Biotechnologies, Inc. Announces Exclusive Distribution Agreement With VisionPlus Corp. for TearScan(R) Lactoferrin and IgE Diagnostic Tests in South Korea
23-10-2025
yahoo.com
AXIM Biotechnologies Announces Exclusive Latin America License & Distribution Agreement With JK Medical for TearScan(R) Ocular Diagnostic Tests
07-10-2025
yahoo.com
What is the current price of AXIM BIOTECHNOLOGIES INC (AXIM:OTCMKTS)?
The current price of AXIM BIOTECHNOLOGIES INC (AXIM:OTCMKTS) is $0.00595.
AXIM BIOTECHNOLOGIES INC (AXIM:OTCMKTS) absolute price change since previous trading day?
The absolute price change of AXIM BIOTECHNOLOGIES INC (AXIM:OTCMKTS) since the previous trading day is $-5e-05.
AXIM BIOTECHNOLOGIES INC (AXIM:OTCMKTS) percentage price change since previous trading day?
The percentage price change of AXIM BIOTECHNOLOGIES INC (AXIM:OTCMKTS) since the previous trading day is -0.8333%.
What is the most recent average sentiment score for AXIM BIOTECHNOLOGIES INC (AXIM:OTCMKTS)?
The most recent average sentiment score for AXIM BIOTECHNOLOGIES INC (AXIM:OTCMKTS) is 88 out of 100.
What is the most recent average sentiment for AXIM BIOTECHNOLOGIES INC (AXIM:OTCMKTS)?
The most recent sentiment for AXIM BIOTECHNOLOGIES INC (AXIM:OTCMKTS) is .
SEC-8K** Filing Available For AXIM BIOTECHNOLOGIES INC (AXIM:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.